Publications
IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.
Homo- and hetero-oligomerization of beta-arrestins in living cells.J. Biol. Chem. 2005-12-02;280(48):40210-5.
Multiplex multidimensional nanoLC-MS system for targeted proteomic analyses.Electrophoresis 2005-12-01;26(24):4575-89.
Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins.Anal. Chem. 2005-12-01;77(23):7774-82.
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome.Int. Immunol. 2005-12-01;17(12):1583-96.
Further evidence that ribavirin interacts with eIF4E.RNA 2005-12-01;11(12):1762-6.
Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells.Mol. Pharmacol. 2005-12-01;68(6):1852-62.
Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells.Blood 2005-12-01;106(12):3988-94.
A new catalog of protein beta-sheets.Proteins 2005-11-15;61(3):545-58.
T cells targeted against a single minor histocompatibility antigen can cure solid tumors.Nat. Med. 2005-11-01;11(11):1222-9.
EN2 is a candidate oncogene in human breast cancer.Oncogene 2005-10-20;24(46):6890-901.

Follow IRIC: